Skip to main content

Advertisement

SpringerLink
Log in

Epstein-Barr virus-related lymphoproliferative disorders

  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Esptein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that persists in carriers as a lifelong, mostly asymptomatic infection. EBV is associated with a variety of lymphomas and lymphoproliferative disorders. In this review we provide an update of the relevant literature on EBV-associated lymphoproliferative disorders, with particular emphasis on epidemiology, pathogenesis, and novel treatment approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030–3044.

    Article  PubMed  CAS  Google Scholar 

  2. Ushiku T, Chong JM, Uozaki H, et al.: p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2007, 120:60–66.

    Article  PubMed  CAS  Google Scholar 

  3. Hjalgrim H, Smedby KE, Rostgaard K, et al.: Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res 2007, 67:2382–2388.

    Article  PubMed  CAS  Google Scholar 

  4. Landgren O, Engels EA, Pfeiffer RM, et al.: Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 2006, 98:1321–1330.

    Article  PubMed  Google Scholar 

  5. Gandhi MK, Lambley E, Burrows J, et al.: Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin’s lymphoma. Clin Cancer Res 2006, 12:460–464.

    Article  PubMed  CAS  Google Scholar 

  6. Musacchio JG, Carvalho Mda G, Morais JC, et al.: Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin’s disease. Sao Paulo Med J 2006, 124:154–157.

    Article  PubMed  Google Scholar 

  7. Hirose Y, Masaki Y, Sawaki T, et al.: Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan. Eur J Haematol 2006, 76:109–118.

    Article  PubMed  CAS  Google Scholar 

  8. Biggar RJ, Jaffe ES, Goedert JJ, et al.: Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006, 108:3786–3791.

    Article  PubMed  CAS  Google Scholar 

  9. Engels EA, Pfeiffer RM, Goedert JJ, et al.: Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006, 20:1645–1654.

    Article  PubMed  Google Scholar 

  10. Newton R, Carpenter L, Casabonne D, et al.: A prospective study of Kaposi’s sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Cancer 2006, 94:1504–1509.

    Article  PubMed  CAS  Google Scholar 

  11. Fellner MD, Durand K, Correa RM, et al.: Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Int J Infect Dis 2007, 11:172–178.

    Article  PubMed  CAS  Google Scholar 

  12. Bonnet F, Jouvencel AC, Parrens M, et al.: A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. J Clin Virol 2006, 36:258–263.

    Article  PubMed  Google Scholar 

  13. Lee TC, Savoldo B, Barshes NR, et al.: Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clin Transplant 2006, 20:389–393.

    Article  PubMed  Google Scholar 

  14. Lee TC, Goss JA, Rooney CM, et al.: Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 2006, 20:689–694.

    Article  PubMed  Google Scholar 

  15. Brauninger A, Schmitz R, Bechtel D, et al.: Molecular biology of Hodgkin’s and Reed/Sternberg cells in Hodgkin’s lymphoma. Int J Cancer 2006, 118:1853–1861.

    Article  PubMed  CAS  Google Scholar 

  16. Diepstra A, van Imhoff GW, Karim-Kos HE, et al.: HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin’s lymphoma. J Clin Oncol 2007, 25:3101–3108.

    Article  PubMed  Google Scholar 

  17. Gandhi MK, Lambley E, Duraiswamy J, et al.: Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 2006, 108:2280–2289.

    Article  PubMed  CAS  Google Scholar 

  18. Marshall NA, Culligan DJ, Tighe J, et al.: The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin’s lymphoma. Exp Hematol 2007, 35:596–604.

    Article  PubMed  CAS  Google Scholar 

  19. Sauce D, Larsen M, Curnow SJ, et al.: EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood 2006, 108:11–18.

    Article  PubMed  CAS  Google Scholar 

  20. Asada H: Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci 2007, 45:153–160.

    Article  PubMed  CAS  Google Scholar 

  21. Cho JH, Kim HS, Ko YH, Park CS: Epstein-Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite. J Infect 2006, 52:e173–e176.

    Article  PubMed  Google Scholar 

  22. Iwatsuki K, Satoh M, Yamamoto T, et al.: Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006, 142:587–595.

    Article  PubMed  CAS  Google Scholar 

  23. Asano N, Oshiro A, Matsuo K, et al.: Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin’s lymphoma: a clinicopathologic study. J Clin Oncol 2006, 24:4626–4633.

    Article  PubMed  Google Scholar 

  24. Dutton A, Woodman CB, Chukwuma MB, et al.: Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood 2007, 109:2597–2603.

    Article  PubMed  CAS  Google Scholar 

  25. Kim LH, Peh SC, Poppema S: Expression of retino-blastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Hum Pathol 2006, 37:92–100.

    Article  PubMed  CAS  Google Scholar 

  26. Smith C, Cooper L, Burgess M, et al.: Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope. J Immunol 2006, 177:4897–4906.

    PubMed  CAS  Google Scholar 

  27. Savoldo B, Rooney CM, Di Stasi A, et al.: Epstein Barr virus-specific cytotoxic T lymphocytes expressing the anti-CD30(zeta) artificial chimeric T-cell receptor for immunotherapy of Hodgkin’s disease. Blood 2007, In press.

  28. Cho HI, Hong YS, Lee MA, et al.: Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas. Int J Hematol 2006, 83:66–73.

    Article  PubMed  Google Scholar 

  29. Demachi-Okamura A, Ito Y, Akatsuka Y, et al.: Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies. Eur J Immunol 2006, 36:593–602.

    Article  PubMed  CAS  Google Scholar 

  30. Choquet S, Leblond V, Herbrecht R, et al.: Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 2006, 107:3053–3057.

    Article  PubMed  CAS  Google Scholar 

  31. Savoldo B, Goss JA, Hammer MM, et al.: Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood 2006, 108:2942–2949.

    Article  PubMed  CAS  Google Scholar 

  32. Humar A, Hebert D, Davies HD, et al.: A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder. Transplantation 2006, 81:856–861.

    Article  PubMed  CAS  Google Scholar 

  33. Green M, Michaels MG, Katz BZ, et al.: CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant 2006, 6:1906–1912.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB 389, Baltimore, MD, 21231, USA

    Richard F. Ambinder

Authors
  1. Nina D. Wagner-Johnston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard F. Ambinder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard F. Ambinder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner-Johnston, N.D., Ambinder, R.F. Epstein-Barr virus-related lymphoproliferative disorders. Curr Hematol Malig Rep 2, 249–254 (2007). https://doi.org/10.1007/s11899-007-0034-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-007-0034-y

Keywords

Search

Navigation